PROTEOLYTIC PROCESSING OF VON-WILLEBRAND-FACTOR SUBUNIT - HETEROGENEITY IN TYPE-IIA VON-WILLEBRAND DISEASE

被引:10
|
作者
BATLLE, J
LASIERRA, J
VILLAMOR, AF
NAVARRO, JL
PARDO, A
CAMPOS, M
JUSTICA, B
FERNANDEZ, MFL
机构
[1] HOSP SAN MILLAN, LOGRONO, SPAIN
[2] HOSP RAMON Y CAJAL, E-28034 MADRID, SPAIN
[3] HOSP SANTO ANTONIO, OPORTO, PORTUGAL
关键词
VWF; IIA VON WILLEBRAND DISEASE; VWF SUBUNIT;
D O I
10.1007/BF01727414
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type IIA von Willebrand disease (vWD) is a heterogeneous disorder for which two different pathogenetic mechanisms have been proposed: increased proteolytic susceptibility of von Willebrand factor (vWF), and/or interference of its post-translational processing. Subunit analysis of vWF in type-IIA vWD has revealed an increased relative proportion of the 176- and 140-kDa subunit-derived fragments, suggesting an augmented fragmentation of vWF, even in the resting state. We analyzed the subunit pattern of vWF in plasma from five previously described patients with type-IIA vWD. All of them showed the above-mentioned pattern. In addition, the presence of a new band with an apparent molecular mass of 200 kDa, not described in normal individuals or in patients with vWD, was repeatedly observed in one of these patients. This patient also exhibited an abnormal vWF multimeric structure in platelets and in plasma, before and after desmopressin administration, when the blood was collected either in the presence or in the absence of proteinase inhibitors. We believe that an abnormal primary structure of vWF could be responsible for this abnormal proteolytic fragmentation pattern, as well as for the abnormal multimerization of vWF. Moreover, an abnormal susceptibility to proteolysis appears to be present, as suggested by the increase in the relative proportion of the 176-kDa fragment observed in the same patient. Future sequencing studies and genetic analysis may clarify whether there are one or two different defects related to the vWF of that patient. Our results indicate that the subunit analysis of vWF may reveal additional defects present in type-IIA vWD that may help our understanding of the pathogenesis of such disease.
引用
收藏
页码:111 / 115
页数:5
相关论文
共 50 条
  • [21] HUMAN INHIBITORS FROM SEVERE VON-WILLEBRAND DISEASE PATIENTS INHIBIT VON-WILLEBRAND-FACTOR BINDING TO COLLAGEN
    BATLLE, J
    BOSCH, N
    CASTILLO, R
    MONTEAGUDO, J
    LOPEZ, MJB
    FERNANDEZ, MFL
    [J]. THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1182 - 1182
  • [22] 3 DISTINCT CANDIDATE POINT MUTATIONS OF THE VON WILLEBRAND FACTOR GENE IN 4 PATIENTS WITH TYPE-IIA VON WILLEBRAND DISEASE
    SUGIURA, I
    MATSUSHITA, T
    TANIMOTO, M
    TAKAHASHI, I
    YAMAZAKI, T
    YAMAMOTO, K
    TAKAMATSU, J
    KAMIYA, T
    SAITO, H
    [J]. THROMBOSIS AND HAEMOSTASIS, 1992, 67 (06) : 612 - 617
  • [23] POSTTRANSFUSION ANAPHYLACTIC REACTIONS IN A PATIENT WITH SEVERE VON-WILLEBRAND DISEASE - ROLE OF COMPLEMENT AND ALLOANTIBODIES TO VON-WILLEBRAND-FACTOR
    BERGAMASCHINI, L
    MANNUCCI, PM
    FEDERICI, AB
    COPPOLA, R
    GUZZONI, S
    AGOSTONI, A
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1995, 125 (03): : 348 - 355
  • [24] HEMOSTATIC RESPONSE TO ALPHANATE(TM), A FACTOR-VIII CONCENTRATE CONTAINING VON-WILLEBRAND-FACTOR, IN PATIENTS WITH VON-WILLEBRAND DISEASE TYPE-2A (IIA AND IIC MIAMI)
    LEDFORD, MR
    BYRNES, JJ
    DELGADO, L
    BRITO, MI
    LIEBMANN, AS
    [J]. THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1174 - 1174
  • [25] STUDY OF THE FACTOR-VIII-BINDING DOMAIN OF VON-WILLEBRAND-FACTOR IN 55 PATIENTS WITH VARIOUS TYPES OF VON-WILLEBRAND DISEASE
    PIAO, YC
    LAVERGNE, JM
    GIRMA, JP
    ROTHSCHILD, C
    SIE, P
    BAHNAK, BR
    MEYER, D
    [J]. THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 559 - 559
  • [26] ARG578GLN MUTATIONS IN THE VON-WILLEBRAND-FACTOR GENE IN 3 UNRELATED CASES OF TYPE-IIB VON-WILLEBRAND DISEASE
    PIAO, YC
    LAVERGNE, JM
    BOYERNEUMANN, C
    SCHANDELONG, A
    ALESSI, MC
    MEYER, D
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (05) : 787 - 789
  • [27] NEW VARIANT OF VON-WILLEBRAND DISEASE TYPE-II WITH MARKEDLY INCREASED LEVELS OF VON-WILLEBRAND FACTOR ANTIGEN AND DOMINANT MODE OF INHERITANCE - VON-WILLEBRAND DISEASE TYPE-IIC MIAMI
    LEDFORD, MR
    RABINOWITZ, I
    SADLER, JE
    KENT, JW
    CIVANTOS, F
    [J]. BLOOD, 1993, 82 (01) : 169 - 175
  • [28] VON-WILLEBRAND DISEASE (VWD) IN THE RIIIS/J-MOUSE IS DUE TO A DEFECT OUTSIDE OF THE VON-WILLEBRAND-FACTOR (VWF) GENE
    MOHLKE, KL
    NICHOLS, WC
    COONEY, KA
    YANG, A
    BRUCK, ME
    SWANK, RT
    GINSBURG, D
    [J]. THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1006 - 1006
  • [29] TYPE-2 VON-WILLEBRAND DISEASE RESULTING FROM AN INSERTION OR DELETION IN THE 509-695 DISULFIDE LOOP OF VON-WILLEBRAND-FACTOR
    GAUCHER, C
    HILBERT, L
    MERIANE, F
    MAZURIER, C
    PERNOD, G
    [J]. THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1168 - 1168
  • [30] A NOVEL VON-WILLEBRAND-FACTOR, ARG611CYS OR VWF COLUMBIA, ASSOCIATED WITH A DOMINANT VON-WILLEBRAND DISEASE VARIANT
    HAKAMI, N
    SHIBUYA, H
    JOHNSON, GS
    STOY, SJ
    HUANG, THM
    MONTGOMERY, RR
    [J]. BLOOD, 1993, 82 (10) : A149 - A149